Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Wickerson (Toronto, Canada), D. Brooks (Toronto, Canada), J. Granton (Toronto, Canada), L. Singer (Toronto, Canada), D. Rozenberg (Toronto, Canada), D. Reid (Toronto, Canada), S. Mathur (Toronto, Canada). Interval versus continuous cycling in advanced interstitial lung disease. 3831

Member's Comments

No comment yet.

Related content which might interest you: Interval versus continuous training in patients with end stage lung disease before lung transplantation Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD) Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure Year: 2009 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD) Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease) Source: International Congress 2016 – GR2 Radiology Year: 2016 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005 Interval training as an alternative modality to continuous exercise in patients with COPD Source: Eur Respir J 2002; 20: 12-19 Year: 2002 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 The relation of six-minute walk test and lung function in interstitial lung disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs) Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD Source: Eur Respir J 2004; 24: Suppl. 48, 215s Year: 2004 Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016